National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1411613



Case Details

VAERS ID: 1411613 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-02
Onset:2021-06-04
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Dysmenorrhoea, Nausea, Presyncope, Syncope, Vision blurred
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Cardiomyopathy (broad), Lens disorders (broad), Retinal disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021655512

Write-up: Blurring of vision; Period pains; Near fainting; Nausea; Fainting; This is a spontaneous report from a contactable consumer received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106040750499600-Y7XHU and Safety Report Unique Identifier GB-MHRA-ADR 25418332. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jun2021 as single dose for COVID-19 immunisation. Medical history included pregnancy. She was no longer pregnant at the time of reporting. She has not had symptoms associated with COVID-19, not had a COVID-19 test, and not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced nausea and fainting on an unspecified date; period pains and near fainting on 04Jun2021. Case narrative: Period started and was accompanied by extreme nausea, pains and fainting/temporary blurring of vision on an unspecified date. This lasted for around 40 minutes and was very different to normal period reactions. She has not tested positive for COVID-19 since having the vaccine. The patient recovered from nausea and fainting on an unspecified date; recovering from period pains and near fainting; while outcome of blurring of vision was unknown. Case was reported as medically significant by health authority. No follow-up attempts are needed, information about batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1411613


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166